Retinal abnormatilites as a diagnostic or prognostic marker of schizophrenia
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985904%3A_____%2F18%3A00495782" target="_blank" >RIV/67985904:_____/18:00495782 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216224:14310/18:00106671 RIV/00179906:_____/18:10379398 RIV/00216208:11150/18:10379398
Výsledek na webu
<a href="http://dx.doi.org/10.5507/bp.2018.035" target="_blank" >http://dx.doi.org/10.5507/bp.2018.035</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5507/bp.2018.035" target="_blank" >10.5507/bp.2018.035</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Retinal abnormatilites as a diagnostic or prognostic marker of schizophrenia
Popis výsledku v původním jazyce
The review is a summary of structural and functional changes in the human retina observed in patients with schizophrenia. The main focus is on the potential of these changes to serve as schizophrenia-specific biomarkers accessible to clinicians. We identified three features of the retina that can be detected non-invasively in humans and which appear to show charateristic changes in schizophrenia: (1) retinal microvasculature displaying abnormally wide venules, (2) electroretinograms indicating altered function of photoreceptors or other cells in the retinal component of the visual pathway, (3) optical coherence tomography pointing to structural differences between the retinae of patients with schizophrenia and those of healthy volunteers. We propose that the most feasible approach to evaluating the data would be to study the genetic and epigenetic background of the schizophrenia-associated retinal abnormalities and establish their significance and specificity as potential biomarkers for the disease. The studies should include longitudinal observations focusing on the possible involvement of medication and comorbid conditions in the mechanism of the disease, a comparison of schizophrenia with other mental disorders, and investigating retinal abnormalities in animal models of psychoses. Biomarkers identified in the process could represent an important addition to the arsenal of non-invasive techniques available to both clinicians and researchers. These novel biomarkers could facilitate research of the biological basis of psychosis and help to address the diagnostic, predicitive, preventative, prophylactic and therapeutic aspects of schizophrenia.
Název v anglickém jazyce
Retinal abnormatilites as a diagnostic or prognostic marker of schizophrenia
Popis výsledku anglicky
The review is a summary of structural and functional changes in the human retina observed in patients with schizophrenia. The main focus is on the potential of these changes to serve as schizophrenia-specific biomarkers accessible to clinicians. We identified three features of the retina that can be detected non-invasively in humans and which appear to show charateristic changes in schizophrenia: (1) retinal microvasculature displaying abnormally wide venules, (2) electroretinograms indicating altered function of photoreceptors or other cells in the retinal component of the visual pathway, (3) optical coherence tomography pointing to structural differences between the retinae of patients with schizophrenia and those of healthy volunteers. We propose that the most feasible approach to evaluating the data would be to study the genetic and epigenetic background of the schizophrenia-associated retinal abnormalities and establish their significance and specificity as potential biomarkers for the disease. The studies should include longitudinal observations focusing on the possible involvement of medication and comorbid conditions in the mechanism of the disease, a comparison of schizophrenia with other mental disorders, and investigating retinal abnormalities in animal models of psychoses. Biomarkers identified in the process could represent an important addition to the arsenal of non-invasive techniques available to both clinicians and researchers. These novel biomarkers could facilitate research of the biological basis of psychosis and help to address the diagnostic, predicitive, preventative, prophylactic and therapeutic aspects of schizophrenia.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30215 - Psychiatry
Návaznosti výsledku
Projekt
<a href="/cs/project/NV16-27243A" target="_blank" >NV16-27243A: Mikrovaskulární abnormality jakožto endofenotyp schizofrenie</a><br>
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2018
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Biomedical Papers
ISSN
1213-8118
e-ISSN
—
Svazek periodika
162
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
CZ - Česká republika
Počet stran výsledku
6
Strana od-do
159-164
Kód UT WoS článku
000445913000001
EID výsledku v databázi Scopus
2-s2.0-85053732474